On Monday, Vaxart Inc (NASDAQ: VXRT) opened lower -5.94% from the last session, before settling in for the closing price of $0.73. Price fluctuations for VXRT have ranged from $0.52 to $1.54 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 1341.69% annually for the last half of the decade. Company’s average yearly earnings per share was noted 32.16% at the time writing. With a float of $225.47 million, this company’s outstanding shares have now reached $227.48 million.
In an organization with 125 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -18.02%, operating margin of -427.81%, and the pretax margin is -430.07%.
Vaxart Inc (VXRT) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Vaxart Inc is 0.89%, while institutional ownership is 23.26%. The most recent insider transaction that took place on Jun 18 ’24, was worth 13,578. In this transaction Director of this company bought 20,000 shares at a rate of $0.68, taking the stock ownership to the 78,125 shares.
Vaxart Inc (VXRT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 32.16% per share during the next fiscal year.
Vaxart Inc (NASDAQ: VXRT) Trading Performance Indicators
Check out the current performance indicators for Vaxart Inc (VXRT). In the past quarter, the stock posted a quick ratio of 0.83. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.41, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of Vaxart Inc (VXRT)
Let’s dig in a bit further. During the last 5-days, its volume was 2.83 million. That was better than the volume of 2.41 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 70.62%. Additionally, its Average True Range was 0.06.
During the past 100 days, Vaxart Inc’s (VXRT) raw stochastic average was set at 28.53%, which indicates a significant decrease from 62.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 110.28% in the past 14 days, which was higher than the 84.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6665, while its 200-day Moving Average is $0.7859. However, in the short run, Vaxart Inc’s stock first resistance to watch stands at $0.7516. Second resistance stands at $0.8158. The third major resistance level sits at $0.8616. If the price goes on to break the first support level at $0.6416, it is likely to go to the next support level at $0.5958. Assuming the price breaks the second support level, the third support level stands at $0.5316.
Vaxart Inc (NASDAQ: VXRT) Key Stats
There are currently 227,480K shares outstanding in the company with a market cap of 156.37 million. Presently, the company’s annual sales total 7,380 K according to its annual income of -82,470 K. Last quarter, the company’s sales amounted to 4,930 K and its income totaled -14,080 K.
